Perioperative management of patients with neuromuscular diseases

Close metadata

Recommended articles:

Anesthesia for adults in outpatient surgery. Russian Journal of Anesthesiology and Reanimatology. 2024;(2):6-31

Optimal prevention of VTE in cancer surgery patients with impaired renal function. Pirogov Russian Journal of Surgery. 2024;(1):119-126

Diagnosis of septic complications of postpartum endometritis and treatment of laboring women. Russian Bulletin of Obstetrician-Gynecologist. 2024;(1):69-75

Endobronchial hamartoma. P.A. Herzen Journal of Oncology. 2024;(1):59-62

Convexity hyperostotic meningioma en plaque: a systematic review. Burdenko's Journal of Neurosurgery. 2024;(1):103-108

The role of anatomical study of the volume of the pterygomandibular space using silicone injection as a predictor of safe anesthesia in the lower jaw. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(1):42-46

Fertility-sparing treatment in cancer patients: how can we help in the 21st century?. Russian Journal of Human Reproduction. 2024;(1):26-63

Differential diagnosis of volumetric formation of the pelvic organs and abdominal cavity in the practice of an obstetrician-gynecologist and neurosurgeon using the example of serozocele (seroma). Russian Journal of Human Reproduction. 2024;(1):116-121

Minimally invasive surgical treatment of extramedullary tumors at the level of craniovertebral junction: experience of the Burdenko Neurosurgical Center. Burdenko's Journal of Neurosurgery. 2024;(2):39-46

Patient-centered approach to assessing tolerability of antitumor treatment for oral cavity and oropharyngeal cancer. P.A. Herzen Journal of Oncology. 2024;(2):21-26

ABSTRACT The clinical guidelines present modern methods of perioperative treatment of surgical patients with neuromuscular diseases. Various methods of anesthesia are considered, indications and contraindications, advantages and disadvantages of general and regional anesthesia are substantiated, and features of monitoring and intensive care of patients with neuromuscular disorders.

Keywords:

neuromuscular diseases

muscular weakness

surgery

anesthesia

intensive therapy

perioperative monitoring

perioperative period

preoperative period

postoperative period

Authors:

Zabolotskikh I.B.

FGBOU VO «Kuban State Medical University» Ministry of Health of Russia, Krasnodar, Russia

SPIN RSCI: 5142-1661
Scopus AuthorID: 6508104506
ResearcherID: O-2705-2014
ORCID: 0000-0002-3623-2546

Belkin A.A.

Brain Institute Clinic;
Ural State Medical University

SPIN RSCI: 6683-4704
Scopus AuthorID: 7006908480
ORCID: 0000-0002-0544-1492

Butrov A.V.

RUDN University: PFUR, Moscow, Russia

Kondratiev A.N.

Polenov Neurosurgical Institute of thr Ministry of Health of the Russia, 197341, Saint Petersburg, Russia

Lebedinskii K.M.

FGBOU VO «North-West State Medical University named after I.I. Mechnikov» Ministry of Health of Russia, St. Petersburg, Russia

SPIN RSCI: 3590-2308
Scopus AuthorID: 6602775085
ResearcherID: O-8655-2014
ORCID: 0000-0002-5752-4812

Lubnin A.Yu.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia, N.N. Burdenko Research Institute of Neurosurgery, Moscow, Russia, Department of Obstetrics and Gynecology, M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia

RSCI AuthorID: 370609
Scopus AuthorID: 57192157123
ORCID: 0000-0003-2595-5877

Magomedov M.A.

Pirogov Russian National Research Medical University of the Ministry of Health of the Russia, 117997, Moscow, Russia

SPIN RSCI: 6195-3616
Scopus AuthorID: 57211443228
ORCID: 0000-0002-1972-7336

Nikolaenko E.M.

NCUS «Scientific clinical center of open joint stock company «Russian Railways», Moscow, Russia

Ovechkin A.M.

FGAOU VO «The First Moscow State Medical University named after I.M. Sechenov» Ministry of Health of Russia, Moscow, Russia

SPIN RSCI: 1277-9220
Scopus AuthorID: 23474305000
ResearcherID: AAP-3404-2021
ORCID: 0000-0001-7629-6280

Shifman E.M.

M.F. Vladimirsky Moscow Regional Research Clinical Institute, Ministry of Health of the Moscow Region, Moscow, Russia

SPIN RSCI: 4582-8494
Scopus AuthorID: 6507655298
ResearcherID: AAY-3981-2020
ORCID: 0000-0002-6113-8498

Schegolev A.V.

N.N. Burdenko Main Military Clinical Hospital, Moscow, Russia ,SM Kirov Military Medical Academy, St. Petersburg, Russia

SPIN RSCI: 4107-6860
Scopus AuthorID: 7003338841
ResearcherID: J-4326-2013
ORCID: 0000-0001-6431-439X

List of references:

Nevrologiya: nacional’noe rukovodstvo. Pod red. Guseva EI, Konovalova AN, Skvorcovoj VI, Gekht AB. M.: GEOTAR-Media, 2009. (In Russ.)
Nevrologiya: nacional’noe rukovodstvo. Kratkoe izdanie. Pod red. Guseva EI, Konovalova AN, Gekht AB. M.: GEOTAR-Media, 2014. (In Russ.)
Martin LJ, Price AC, Kaiser A, Shaikh AY, Liu Z. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (review). International Journal of Molecular Medicine. 2000;5:3-13.
Kapur S, Kumar S, Eagland K. Anesthetic management of a parturient with neurofibromatosis 1 and Charcot-Marie-Tooth disease. Journal of Clinical Anesthesia. 2007;19:405-406.
Dermietzel R. Gap junction wiring: A «new» principle in cell-to-cell communication in the nervous system? Brain Research Reviews. 1998;26:176-183.
Hahn AF, Ainsworth PJ, Naus CC, Mao J, Bolton CF. Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle and Nerve. 2000;999(9):S39-S48.
Schaefer AM, Taylor RW, Turnbull DM. The mitochondrial genome and mitochondrial muscle disorders. Current Opinion in Pharmacology. 2001;1:288-293.
Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nature Medicine. 2001;7:365-368.
Lindstrom JM. Acetylcholine receptors and myasthenia. Muscle and Nerve. 2000;23:453-477.
Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasm. American Journal of Physiology. 1956;187:612-613.
Koch MC, Steinmeyer K, Lorenz C, Ricker K, Wolf F, Otto M, Zoll B, Lehmann-Horn F, Grzeschik KH, Jentsch TJ. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science. 1992;257(5071):797-800.
Fontaine B, Khurana TS, Hoffman EP, Bruns GA, Haines JL, Trofatter JA, Hanson MP, Rich J, McFarlane H, Yasek DM. Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science. 1990;250(4983):1000-1002.
Lehmann-Horn F, Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiological Reviews. 1999;79:1317-1372.
Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs’ syndrome). Report of five cases and literature review. Brain. 1993;116(Pt 2):453-469.
Arimura K, Sonoda Y, Watanabe O, Nagado T, Kurono A, Tomimitsu H, Otsuka R, Kameyama M, Osame M. Isaacs’ syndrome as a potassium channelopathy of the nerve. Muscle and Nerve. 2002;11:S55-S58.
Thiel RE. The myotonic response to suxamethonium. British Journal of Anaesthesia. 1967;39:815-820.
Ryan JF. Malignant hyperthermia: treatment and after care. Anesthesiology Clinics of North America. 1991;4:913-932.
Young CC, Sladen RN. Hyperthermia. In: Complications in Anesthesia, 2nd ed. Atlee JL. (ed.). 2007;423-426.
Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handbook of Clinical Neurology. 2016;138:225-238.
Naguib M, Lien CA. Pharmacology of muscle relaxants and their antagonists. In Miller RD (ed): Miller’s Anesthesia, 6th ed. New York: Churchill Livingstone; 2005:481-572.
Dong-Chan Kim. Malignant hyperthermia. Korean Journal of Anesthesiology. 2012;63(5):391-401.
Laghi F, Tobin MJ. Disorders of the respiratory muscles. American Journal of Respiratory and Critical Care Medicine. 2003;168:10-48.
Juel VC, Bleck TP. Neuromuscular disorders in the ICU. In Fink MP., Abraham E, Vincent J-L, Kochanek PM, eds. Textbook of Critical Care (5 eds.); 2005.
EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis; Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) — revised report of an EFNS task force. European Journal of Neurology. 2012;19:360-375.
Nicholson G, Myers S. Intermediate forms of Charcot-Marie-Tooth neuropathy: a review. Neuromolecular Medicine. 2006;8:123-130.
Lawson VH, Gordon Smith A, Bromberg MB. Assessment of axonal loss in Charcot-Marie-Tooth neuropathies. Experimental Neurology. 2003;184:753-757.
Rudnik-Schöneborn S, Röhrig D, Nicholson G, Zerres K. Pregnancy and delivery in Charcot-Marie-Tooth disease type 1. Neurology. 1993;43:2011-2016.
Roland EH. Muscular dystrophy. Pediatrics in Review. 2000;21:233-237.
Brown RH Jr. Dystrophin-associated proteins and the muscular dystrophies. Annual Review of Medicine. 1997;48:457-466.
Emery AE, Dreifuss FE. Unusual type of benign X-linked muscular dystrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 29:338-342, 1966.
Orrell RW, Tawil R, Forrester J, Kissel JT, Mendell JR, Figlewicz DA. Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology. 1999;52:1822-1826.
Johannsen S, Kranke P, Reiners K, Schuster F. Perioperative management of patients with neuromuscular disorders. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 2009 Nov;44(11-12):748-755.
Zeviani M, Amati P, Savoia A. Mitochondrial myopathies. Current Opinion in Rheumatology. 1994;6:559-567.
Clay AS, Behnia M, Brown KK. Mitochondrial disease: A pulmonary and critical care medicine perspective. Chest. 2001;120:634-648.
Badr AE, Mychaskiw G 2nd, Eichhorn JH. Metabolic acidosis associated with a new formulation of propofol. Anesthesiology. 2001;94:536-538.
Krivickas LS, Ansved T, Suh D, Frontera WR. Contractile properties of single muscle fibers in myotonic dystrophy. Muscle and Nerve. 2000;23:529-537.
Harper PS. Myotonic Dystrophy, 3rd ed. London: WBSaunders; 2001.
George ALJr, Crackower MA, Abdalla JA, Hudson AJ, Ebers GC. Molecular basis of Thomsen’s disease (autosomal dominant myotonia congenita). Nature Genetics. 1993;3:305-310.
Mitchell MM, Ali HH, Savarese JJ: Myotonia and neuromuscular blocking agents. Anesthesiology. 1978;49:44-48.
Jurkat-Rott K, Lehmann-Horn F. Human muscle voltage-gated ion channels and hereditary disease. Current Opinion in Pharmacology. 2001;1:280-287.
Ashwood EM, Russell WJ, Burrow DD. Hyperkalaemic periodic paralysis and anaesthesia. Anaesthesia. 1992;47:579-584.
Quane KA, Healy JM, Keating KE, Manning BM, Couch FJ, Palmucci LM, Doriguzzi C, Fagerlund TH, Berg K, Ording H. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nature Genetics. 1993;5:51-55.
Lehmann-Horn F, Jurkat-Rott K, Rudel R. Periodic paralysis: Understanding channelopathies. Current Neurology and Neuroscience Reports. 2002;2:61-69.
Jurkat-Rott K, Lerche H, Lehmann-Horn F. Skeletal muscle channelopathies. Journal of Neurology. 2002;249:1493-1502.
Kleopa KA, Barchi RL. Genetic disorders of neuromuscularion channels. Muscle and Nerve. 26:299-325, 2002.
Whitney KD, McNamara JO. Autoimmunity and neurological disease: Antibody modulation of synaptic transmission. Annual Review of Neuroscience. 1999;22:175-195.
Lebedinsky KM, Triadsky AA, Obolensky SV. Malignant hyperthermia: a pharmacogenetic caused by acute massive rhabdomyolysis. Anesteziologiya i reanimatologiya. 2008;4:66-70. (In Russ.).
Racca F, Mongini T, Wolfler A, Vianello A, Cutrera R, Del Sorbo L, Capello EC, Gregoretti C, Massa R, De Luca D, Conti G, Tegazzin V, Toscano A, Ranieri VM. Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders. Minerva Anestesiologica. 2013;79(4):419-433.
Racca F, Del Sorbo L, Mongini T, Vianello A, Ranieri VM. Respiratory management of acute respiratory failure in neuromuscular diseases. Minerva Anestesiologica. 2010;76:51-62.
Schieren, Mark; Defosse, Jerome; Böhmer, Andreas; Wappler, Frank; Gerbershagen, Mark U. Anaesthetic management of patients with myopathies. European Journal of Anaesthesiology. 2017;34(10):641-649. https://doi.org/10.1097/EJA.0000000000000672
Graham RJ, Athiraman U, Laubach AE, Sethna NF. Anesthesia and perioperative medical management of children with spinal muscular atrophy. Paediatric Anaesthesia. 2009;19:1054-1063.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurology. 2010;9:77-93.
Eichhorn JH, Cooper JB, Cullen DJ, Maier WR, Philip JH, Seeman RG. Standarts of patient monitoring during anesthesia at Harvard Medical School. Journal of the American Medical Association. 1986;256:1017-1020.
Ali HH, Savarese JJ. Monitoring of neuromuscular function. Anesthesiology. 1976;45:216-249.
Viby-Mogensen J, Jensen E, Wrner M, Nielsen HK. Measurement of acceleration: A new method of monitoring neuromuscular function. Acta Anaesthesiologica Scandinavica. 1988;32:45-49.
Butrov AV, Drobyshev MF, Kiselevich VE. Tekhnologiya ispol’zovaniya miorelaksantov na osnove monitoringa nejromyshechnoj provodimosti. M.: Izd-vo NCSSKH im. A.N. Bakuleva RAMN, 1999. (In Russ.)
Klingler W, Lehmann-Horn F, Jurkat-Rott K. Complications of anaesthesia in neuromuscular disorders. Neuromuscular Disorders. 2005;15:195-206.
Vianello A, Arcaro G, Braccioni F, Gallan F, Marchi MR, Chizio S, Zampieri D, Pegoraro E, Salvador V. Prevention of extubation failure in highrisk patients with neuromuscular disease. Journal of Critical Care. 2011;26:517-524.
Birnkrant DJ. The American College of Chest Physicians consensus statement on the respiratory and relatedmanagement of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Pediatrics. 2009; 123(Suppl 4):S242-244.
Rubino FA. Perioperative management of patients with neurologic disease. Neurologic Clinics. 2004;22:261-276.
Muenster T, Mueller C, Forst J, Huber H, Schmitt HJ. Anaesthetic management in patients with Duchenne muscular dystrophy undergoing orthopaedic surgery: a review of 232 cases. European Journal of Anesthesiology. 2012;29:489-494.
Ames WA, Hayes JA, Crawford MW. The role of corticosteroids in Duchenne muscular dystrophy: a review for the anesthetist. Paediatric Anaesthesia. 2005;15:3-8.
Sofocleous CT, Schur I, Cooper SG, Quintas JC, Brody L, Shelin R. Sonographically guided placement of peripherally inserted central venous catheters: review of 355 procedures. The American Journal of Roentgenology. 1998;170:1613-1666.
Troianos CA, Hartman GS, Glas KE, Skubas NJ, Eberhardt RT, Walker JD, Reeves ST; Councils on Intraoperative Echocardiography and Vascular Ultrasound of the American Society of Echocardiography; Society of Cardiovascular Anesthesiologists. Special articles: guidelines for performing ultrasound guided vascular cannulation: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesthesia and Analgesia. 2012;114:46-72.
Morimoto Y, Mii M, Hirata T, Matayoshi H, Sakabe T. Target-controlled infusion of propofol for a patient with myotonic dystrophy. Journal of Anesthesia. 2005;19:336-338.
Allen GC. Bispectral index and mitochondrial myopathies. Anesthesiology. 2003;98:282.
Upton AR, McComas AJ. The double crush in nerve entrapment syndromes. Lancet. 1973;2:359-362.
Gross JB, Bachenberg KL, Benumof JL, Caplan RA, Connis RT, Coté CJ, Nickinovich DG, Prachand V, Ward DS, Weaver EM, Ydens L, Yu S; American Society of Anesthesiologists Task Force on Perioperative Management. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology. 2006;104:1081-1093.
Schmitt HJ, Muenster T. Anesthesia in patients with neuromuscular disorders. Minerva Anestesiologica. 2009;75:632-637.
Hara K, Sakura S, Saito Y, Maeda M, Kosaka Y. Epidural anesthesia and pulmonary function in a patient with amyotrophic lateral sclerosis. Anesthesia and Analgesia. 1996;83:878-879.
Kim SJ, Kim EJ, Min BW, Ban JS, Lee SG, Lee JH. Epidural anesthesia for the patient with type IV spinal muscular atrophy. A case report. Korean Journal of Anesthesiology. 2010;59(Suppl):S65-S68.
Brock M, Guinn C, Jones M. Anesthetic management of an obstetric patient with Charcot-Marie-Tooth disease: a case study. AANA Journal. 2009;77(5):335-337.
Veyckemans F. Can inhalation agents be used in the presence of a child with myopathy? Current Opinion in Anesthesiology. 2010;23:348-355.
de Boer HD, van Esmond J, Booij LH, Driessen JJ. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy. Paediatric Anaesthesia. 2009;19:1226-1228.
Unterbuchner C, Fink H, Blobner M. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia. 2010;65:302-305.
Ciafaloni E, Fox DJ, Pandya S, Westfield CP, Puzhankara S, Romitti PA, Mathews KD, Miller TM, Matthews DJ, Miller LA, Cunniff C, Druschel CM, Moxley RT. Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). Journal of Pediatrics. 2009;155:380-385.
Kyriakides T, Angelini C, Schaefer J, Sacconi S, Siciliano G, Vilchez JJ et al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. European Journal of Neurology. 2010;17:767-773.
Driessen JJ. Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist? Current Opinion in Anesthesiology. 2008;21:350-355.
Kochi T, Oka T, Mizuguchi T. Epidural anesthesia for patients with amyotrophic lateral sclerosis. Anesthesia and Analgesia. 1989;68(3):410-412.
Otsuka N, Igarashi M, Shimodate Y, Nakabayashi K, Asano M, Namiki A. Anesthetic management of two patients with amyotrophic lateral sclerosis (ALS). Masui. 2004;53(11):1279-1281.
Arai Y, Yoshida T, Mizuno Y, Miyashita T, Goto T. Epidural Anesthesia with Non-invasive Positive Pressure Ventilation for Laparotomy in a Patient with Amyotrophic Lateral Sclerosis. Masui. 2015;64(10):1062-1064.
Naguib M, Flood P, McArdle JJ, Brenner HR. Advances in neurobiology of the neuromuscular junction: Implications for the anesthesiologist. Anesthesiology. 2002;96:202-231.
Lee D, Lee KC, Kim JY, Park YS, Chang YJ. Total intravenous anesthesia without muscle relaxant in a patient with amyotrophic lateral sclerosis. Journal of Anesthesia. 2008;22:443-445.
Beach TP, Stone WA, Hamelberg W. Circulatory collapse following succinylcholine: Report of a patient with diffuse lower motor neuron disease. Anesthesia and Analgesia. 1971;50:431-437.
Rosenbaum KJ, Neigh JL, Strobel GE. Sensitivity to nondepolarizing muscle relaxants in amyotrophic lateral sclerosis: Report of two cases. Anesthesiology. 1971;35:638-641.
Arnulf I, Similowski T, Salachas F. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. American Journal of Respiratory and Critical Care Medicine. 2000;161:849-856.
Sato K, Morimoto N, Deguchi K, Ikeda Y, Matsuura T, Abe K. Seven amyotrophic lateral sclerosis patients diagnosed only after development of respiratory failure. Journal of Clinical Neuroscience. 2014;21(8):1341-1343.
Radunovic A, Annane D, Rafiq MK, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. The Cochrane Database of Systematic Reviews. 2013;(3):CD004427.
Kotani N, Hirota K, Anzawa N, Takamura K, Sakai T, Matsuki A. Motor and sensory disability has a strong relationship to induction dose of thiopental in patients with the hypertropic variety of Charcot—Marie—Tooth syndrome. Anesthesia and Analgesia. 1996;82:182-186.
Naguib M, Samarkandi AH. Response to atracurium and mivacurium in a patient with Charcot—Marie—Tooth disease. Canadian Journal of Anesthesia. 1998;45:56-59.
Cuesta A, Pedrola L, Sevilla T, García-Planells J, Chumillas MJ, Mayordomo F, LeGuern E, Marín I, Vílchez JJ, Palau F. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot—Marie—Tooth type 4A disease. Nature Genetics. 2002;30:22-25.
Shapiro F, Sethna N, Colan S, Wohl ME, Specht L. Spinal fusion in Duchenne muscular dystrophy: A multidisciplinary approach. Muscle and Nerve. 1992;15:604-614.
Aldwinckle RJ, Carr AS. The anesthetic management of a patient with Emery-Dreifuss muscular dystrophy for orthopedic surgery. Canadian Journal of Anesthesia. 2002;49:467-470.
Rennun M, Goldstein B, Finkelstein Y, Jedeikin R. Continuous propofol anaesthesia for patients with myotonic dystrophy. British Journal of Anaesthesia. 2000;85(3):407-409.
Shiraishi M, Minami K, Kadaya T. A safe anesthetic method using caudal block and ketamine for the child with congenital myotonic dystrophy. Anesthesia and Analgesia. 2002;94:233.
Genever EE. Suxamethonium-induced cardiac arrest in unsuspected pseudohypertrophic muscular dystrophy. Case report. British Journal of Anaesthesia. 1971;43:984-986.
Buzello W, Huttarsch H. Muscle relaxation in patients with Duchenne’s muscular dystrophy. Use of vecuronium in two patients. British Journal of Anaesthesia. 1988;60:228-231.
Uslu M, Mellinghoff H, Diefenbach C. Mivacurium for muscle relaxation in a child with Duchenne’s muscular dystrophy Anesthesia and Analgesia. 1999;89:340-341.
Nightingale P, Healy TE, McGuinness K. Dystrophia myotonica and atracurium. A case report. British Journal of Anaesthesia. 1985;57:1131-1135.
Kaufman L. Dystrophia myotonica and succinylcholine [letter]. Anaesthesia. 2000;55:929.
Buzello W, Krieg N, Schlickewei A. Hazards of neostigmine in patients with neuromuscular disorders. Report of two cases. British Journal of Anaesthesia. 1982;54:529-534.
Noordeen MH, Haddad FS, Muntoni F, Gobbi P, Hollyer JS, Bentley G. Blood loss in Duchenne muscular dystrophy: Vascular smooth muscle dysfunction? Journal of Pediatric Orthopedics. Part B. 1999;8:212-215.
Ricker K. Myotonic dystrophy and proximal myotonic myopathy. Journal of Neurology. 1999;246:334-338.
Maslow A, Lisbon A. Anesthetic considerations in patients with mitochondrial dysfunction. Anesthesia and Analgesia. 1993;76:884-886.
Rosaeg OP, Morrison S, MacLeod JP. Anaesthetic management of labour and delivery in the parturient with mitochondrial myopathy. Canadian Journal of Anesthesia. 1996;43:403-407.
Fricker RM, Raffelsberger T, Rauch-Shorny S, Finsterer J, Müller-Reible C, Gilly H, Bittner RE. Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency. Anesthesiology. 2002;97:1635-1637.
Carroll JE, Zwillich C, Weil JV, Brooke MH. Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology. 1976;26:140-146.
Cros D, Palliyath S, DiMauro S, Ramirez C, Shamsnia M, Wizer B. Respiratory failure revealing mitochondrial myopathy in adults. Chest. 1992;101:824-828.
Farag E, Argalious M, Narouze S, DeBoer GE, Tome J. The anesthetic management of ventricular septal defect (VSD) repair in a child with mitochondrial cytopathy. Canadian Journal of Anesthesia. 2002;49(9):958-962.
Sasano N, Fujita Y, So M, Sobue K, Sasano H, Katsuya H. Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy. Journal of Anesthesiology. 2007;21(1):72-75.
Shipton EA, Prosser DO. Mitochondrial myopathies and anaesthesia. European Journal of Anesthesiology. 2004;21:173-178.
Blichfeldt-Lauridsen L, Hansen BD. Anesthesia and myasthenia gravis. Acta Anaesthesiologica Scandinavica. 2012;56:17-22.
Baraka A. Onset of neuromuscular block in myasthenic patients. British Journal of Anaesthesia. 1992;69:227-228.
Abel M, Eisenkraft JB. Anesthetic implications of myasthenia gravis. Mount Sinai Journal of Medicine. 2002;69:31-37.
Sanders DB. Lambert-Eaton myasthenic syndrome: Clinical diagnosis, immune-mediated mechanisms, and update on therapies. Annals of Neurology.1995;37(Suppl 1):S63-S73.
Sanders DB, Massey JM, Sanders LL, Edwards LJ. A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome. Neurology. 2000;54:603-607.
Nilsson E, Paloheimo M, Müller K, Heinonen J. Halothane-induced variability in the neuromuscular transmission of patients with myasthenia gravis. Acta Anaesthesiologica Scandinavica. 1989;33:395-401.
Rowbottom SJ. Isoflurane for thymectomy in myasthenia gravis. Anaesthesia and Intensive Care. 1989;17:444-447.
Akpolat N, Tilgen H, Gürsoy F, Saydam S, Gürel A. Thoracic epidural anaesthesia and analgesia with bupivacaine for transsternal thymectomy for myasthenia gravis. European Journal of Anesthesiology. 1997;14:220-223.
D’Angelo R, Gerancher JC. Combined spinal and epidural analgesia in a parturient with severe myasthenia gravis. Regional Anesthesia and Pain Medicine. 1998;23:201-203.
Eisenkraft JB, Book WJ, Mann SM, Papatestas AE, Hubbard M. Resistance to succinylcholine in myasthenia gravis: A dose-response study. Anesthesiology. 1988;69:760-763.
Baraka A. Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase. Anaesthesia. 1992;47:217-219.
Smith CE, Donati F, Bevan DR. Cumulative dose-response curves for atracurium in patients with myasthenia gravis. Canadian Journal of Anesthesia. 1989;36:402-406.
De Haes A, Proost JH, De Baets MH, Stassen MH, Houwertjes MC, Wierda JM. Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: A study in myasthenic pigs. Anesthesiology. 2003;98:133-142.
Brown JC, Charlton JE. A study of sensitivity to curare in myasthenic disorders using a regional technique. Journal of Neurology, Neurosurgery, and Psychiatry. 1975;38:27-33.
Small S, Ali HH, Lennon VA, Brown RH Jr, Carr DB, de Armendi A. Anesthesia for an unsuspected Lambert-Eaton myasthenic syndrome with autoantibodies and occult small cell lung carcinoma. Anesthesiology. 1992;76:142-145.
Wright RB. Myasthenia. In Klawans HL, Goetz CG, Tattler CM (eds): Textbook of Clinical Neuropharmacology and Therapeutics. New York: Raven Press; 1992: 505-516.
Yahno NN, Shtul’man DP. Bolezni nervnoj sistemy. V 2 t. (4-e izdanie). M.: Meditsina, 2005. (In Russ.)
Bisinotto FM, Fabri DC, Calcado MS, Perfeito PB, Tostes LV, Sousa GD. Anesthesia for videolaparoscopic cholecystectomy in a patient with Steinert disease. Case report and review of the literature. Revista Brasileira de Anestesiologia. 2010;60:181-91.
Heiman-Patterson T, Martino C, Rosenberg H. Malignant hyperthermia in myotonia congenita. Neurology. 1988;38:810-812.
Arcas M, Sánchez-Ortega JL, García-Muñoz M, Alonso B, del Yelmo F, López-Rodríguez F. Anesthesia for cesarean delivery in a case of myotonia congenita. Revista Española de Anestesiología y Reanimación. 1996;43(4):147-149.
Haeseler G, Störmer M, Bufler J, Dengler R, Hecker H, Piepenbrock S, Leuwer M. Propofol blocks human skeletal muscle sodium channels in a voltage-dependent manner. Anesthesia and Analgesia. 2001;92:1192-1198.
Haeseler G, Störmer M, Mohammadi B, Bufler J, Dengler R, Piepenbrock S, Leuwer M. The anesthetic propofol modulates gating in paramyotonia congenita mutant muscle sodium channels. Muscle and Nerve. 2001;24:736-743.
Weller JF, Elliott RA, Pronovost PJ. Spinal anesthesia for a patient with familial hyperkalemic periodic paralysis. Anesthesiology. 2002;97:259-260.
Allison KR. Muscular dystrophy versus mitochondrial myopathy: the dilemma of the undiagnosed hypotonic child. Paediatric Anaesthesia. 2007;17:1-6.
Flewellen EH, Bodensteiner JB. Anesthetic experience in a patient with hyperkalemic periodic paralysis. Anesthesiological Reviews. 1980;7:44.
Viscomi CM, Ptacek LJ, Dudley D. Anesthetic management of familial hypokalemic periodic paralysis during parturition. Anesthesia and Analgesia. 1999;88:1081-1082.
Lofgren A, Hahn RG. Hypokalemia from intercostal nerve block. Regional Anesthesia. 1994;19:247-254.
Siler JN, Discavage WJ. Anesthetic management of hypokalemic periodic paralysis. Anesthesiology. 1975;43:489-490.
Zisfein J, Sivak M, Aron AM, Bender AN. Isaacs’ syndrome with muscle hypertrophy reversed by phenytoin therapy. Archives of Neurology. 1983;40:241-242.
van den Berg JS, van Engelen BG, Boerman RH, de Baets MH. Acquired neuromyotonia: Superiority of plasma exchange over high-dose intravenous human immunoglobulin. Journal of Neurology. 1999;246:623-625.
Ashizawa T, Butler IJ, Harati Y, Roongta SM. A dominantly inherited syndrome with continuous motor neuron discharges. Annals of Neurology. 1983;13:285-290.
Hosokawa S, Shinoda H, Sakai T, Kato M, Kuroiwa Y. Electrophysiological study on limb myokymia in three women. Journal of Neurology, Neurosurgery, and Psychiatry. 1987;50:877-881.
Morgan PJ. Peripartum management of a patient with Isaacs’ syndrome. Canadian Journal of Anesthesia. 1997;44:1174-1177.
Pollard BDzh. Rukovodstvo po klinicheskoj anesteziologii: Per. s angl. Pod obshch. red. Kolotilova LV., Mal’tseva V.V. M.: MEDpress-inform, 2006. (In Russ.)
Birnkrant DJ, Panitch HB, Benditt JO, Boitano LJ, Carter ER, Cwik VA. American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest. 2007;132:1977-1986.
Maund E, McDaid C, Rice S, Wright K, Jenkins B, Woolacott N. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review. British Journal of Anaesthesia. 2011;106:292-297.
McNicol ED, Tzortzopoulou A, Cepeda MS, Francia MB, Farhat T, Schumann R. Single-dose intravenous paracetamol or propacetamol for prevention or treatment of postoperative pain: a systematic review and meta-analysis. British Journal of Anaesthesia. 2011;106:764-775.
Walker KJ, McGrattan K, Aas-Eng K, Smith AF. Ultrasound guidance for peripheral nerve blockade. The Cochrane Database of Systematic Reviews. 2009;(4):CD006459.
Fowler SJ, Symons J, Sabato S, Myles PS. Epidural analgesia compared with peripheral nerve blockade after major knee surgery: a systematic review and meta-analysis of randomized trials. British Journal of Anaesthesia. 2008;100:154-164.
Niranjan V, Bach JR. Noninvasive management of pediatric neuromuscular ventilatory failure. Critical Care Medicine.1998;26:2061-2065.
Ruscic KJ, Grabitz SD, Rudolph MI, Eikermann M. Prevention of respiratory complications of the surgical patient: actionable plan for continued process improvement. Current Opinion in Anesthesiology. 2017;30(3):399-408.
Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B. Consensus statement for standard of care in spinal muscular atrophy. Journal of Child Neurology. 2007;22:1027-1049.
Almenrader N, Patel D. Spinal fusion surgery in children with non-idiopathic scoliosis: is there a need for routine postoperative ventilation? British Journal of Anaesthesia. 2006;97:851-857.
Marchant WA, Fox R. Postoperative use of a cough-assist device in avoiding prolonged intubation. British Journal of Anaesthesia. 2002;89:644-647.
Wang CH, Bonnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V, Florence JM, Schara U, Schuler PM, Wahbi K, Aloysius A, Bash RO, Béroud C, Bertini E, Bushby K, Cohn RD, Connolly AM, Deconinck N, Desguerre I, Eagle M, Estournet-Mathiaud B, Ferreiro A, Fujak A, Goemans N, Iannaccone ST, Jouinot P, Main M, Melacini P, Mueller-Felber W, Muntoni F, Nelson LL, Rahbek J, Quijano-Roy S, Sewry C, Storhaug K, Simonds A, Tseng B, Vajsar J, Vianello A, Zeller R; International Standard of Care Committee for Congenital Muscular Dystrophy. Consensus statement on standard of care for congenital muscular dystrophies. Journal of Child Neurology. 2010;25:1559-1581.
Bach JR, Goncalves MR, Hamdani I, Winck JC. Extubation of patients with neuromuscular weakness: a new management paradigm. Chest. 2010;137:1033-1039.

Close metadata